|  Cancer
For information, please click
here or call the Office of Continuum Cancer Centers of New
York: (212) 844-6286
Cardiology
No
studies at this time. Please check back at a later date.
Dermatology
Nonablative fractional laser resurfacing for acne scarring in patients with Fitzpatrick skin phototypes IV-VI
Diabetes
Comparing
the Efficacy of Anti-Inflammatory Regimens in the Treatment of
Central Centrifugal Cicatricial Alopecia
Administration of Vitamin D Analog to New Onset Type1 Diabetes
Mellitus Patients to Restore Pancreatic Cell Function
Gastroenterology
Prospective Observational Study of a New Endoscopic Clip for Gastrointestinal Hemostasis
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrier Gastrointestinal Liner System vs. Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Metformin and/or Sulfonylurea Anti-Diabetes Agents
Randomized, double blind, prospective trial investigating the efficacy of Methotrexate in induction and maintenance of steroid free remission in ulcerative colitis (MEthotrexate Response In Treatment of UC)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of PF-00547659 in Subjects with Crohn’s Disease
Water Irrigation Assisted Colonoscopy in an Urban Medical Center - A Pilot Study
Prospective and Retrospective Database of Inflammatory Bowel Disease Patients
Family study in Primary Biliary Cirrhosis
ENtecavir Utilization, Management, and Efficacy in the United States: A MulTi-cEnter Study
A Multicenter Open-Label Extension Study To Assess Long-Term Safety of PF-00547659 In Subjects With Crohn’s Disease
A Phase 3b Study of 2 Treatment Durations of Telaprevir, Peg-IFN (Pegasys®), and Ribavirin (Copegus®) in Treatment-Naive and Prior Relapser Subjects With Genotype 1 Chronic Hepatitis C and IL28B CC Genotype
A Multicenter, Open-Label, Phase 2b Pilot Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir, Peginterferon-Alfa-2, and Ribavirin) in Subjects With Genotype 1 Chronic Hepatitis C With Compensated Cirrhosis
A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon α-2a (Pegasys®) versus Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Non-Cirrhotic Subjects with HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B
A PHASE 3, Dose Response Study of Obeticolic acid (OCA) in Primary Biliary Cirrhosis INT-747-301A and Long-term, Placebo-controlled Clinical Outcomes Study of Obeticholic Acid in Patients with PBC
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV infection: Realm Study
A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatment-resistant mutations or the durability of sustained virological response (SVR) in patients treated with DAA-containing regimens for chronic hepatitis C infection
AIDS and
the Gastrointestinal Tract
Development
Study of Gastrointestingal Disease
Gastrointestinal
Function in HIV Patients
HIV/AIDS
Click
Here
Kidney
No studies at this time. Please check back at a later date.
Mental
Health
Brief
Psychotherapy Research Program (depression/anxiety)
Neurology
For more information, please click here.
Obesity/Weight
Management &
Body Composition
Adult
Body Composition Study
Study of the Severely Obese
Open
Wounds
No studies at this time. Please check back at a later date.
Substance
Abuse
Safe
Steps -Combined Treatment of Alcohol Dependent Women with Posttraumatic
Stress Disorder
Treatment of Heroin or Other Opiate Addiction in Adolescents
Urology
There are no studies at this time. Please check back at a later
date.
Women's
Health
Safe
Steps -Combined Treatment of Alcohol Dependent Women with Posttraumatic
Stress Disorder
Other
Phase
II study to determine if Danazol is an anti-D sparing agent when
used in combination with Anti-D for the treatment of ITP
|